| 15.4 2.19 (16.58%) | 08-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.83 |
1-year : | 24.52 |
| Resists | First : | 17.84 |
Second : | 21 |
| Pivot price | 14.91  |
|||
| Supports | First : | 12.72 |
Second : | 10.59 |
| MAs | MA(5) : | 14.35 |
MA(20) : | 16 |
| MA(100) : | 13.8 |
MA(250) : | 27.75 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 26.3 |
D(3) : | 18.4 |
| RSI | RSI(14): 51.7 |
|||
| 52-week | High : | 86 | Low : | 5.26 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ EUDA ] has closed below upper band by 39.2%. Bollinger Bands are 36.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 16.02 - 16.11 | 16.11 - 16.19 |
| Low: | 13.28 - 13.39 | 13.39 - 13.48 |
| Close: | 15.23 - 15.4 | 15.4 - 15.55 |
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
Fri, 31 Jul 2026
EUDA Health (NASDAQ: EUDA) outlines oncology cell therapy plan - Stock Titan
Tue, 28 Jul 2026
EUDA Health signs MOU for stem cell cancer therapy development - Investing.com
Tue, 28 Jul 2026
EUDA Health Holdings Limited (NASDAQ: EUDA) inks tri-party MOU on iPSC cell therapies - Stock Titan
Mon, 01 Jun 2026
EUDA Health regains Nasdaq listing compliance - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 3 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 41.1 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 2 (K) |
| Shares Short P.Month | 3 (K) |
| EPS | -1.49 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.25 |
| Profit Margin | -40.7 % |
| Operating Margin | -34.8 % |
| Return on Assets (ttm) | -89.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 78.9 % |
| Gross Profit (p.s.) | 1 |
| Sales Per Share | 2.28 |
| EBITDA (p.s.) | -0.75 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -10.41 |
| PEG Ratio | 0 |
| Price to Book value | -6.85 |
| Price to Sales | 6.75 |
| Price to Cash Flow | -18.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|